Table 3 Zeta potential ,particle size and polydispersity index of SLN Formulations
From: Formulation and evaluation of chitosan solid lipid nanoparticles of carbamazepine
Formulation | Size average (d.nm): | Polydispersity index | Zeta potential |
|---|---|---|---|
F1 | 168.7 ± 1.8 nm | 0.206 | −28.9 ± 2.0 mV |
F2 | 187.5 ± 2.8 nm | 0.219 | −27.60 ± 1.8 mV |
F3 | 154.0 ± 1.5 nm | 0.309 | −32.12 ± 1.4 mV |